Researchers at Hannover Medical School have made significant advancements in the production of human immune cells, specifically macrophages, using medium-sized bioreactors.
This innovative method allows for the generation of up to 40 million macrophages each week, derived from induced pluripotent stem cells.
The implications of this research could be substantial, potentially enhancing the availability of immune cells for therapeutic applications.